Report Detail
Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Professional Survey Report 2019
- RnM3808678 |
- 09 October, 2019 |
- Global |
- 102 Pages |
- QYResearch |
- Pharma & Healthcare
Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a group of gastrointestinal hormones called incretins. Incretins help stimulate the production of insulin when it is needed (e.g. after eating) and reduce the production of glucagon by the liver when it is not needed (e.g. during digestion). They also slow down digestion and decrease appetite. So by protecting incretins from damage, DPP-4 inhibitors help regulate blood glucose levels.
Januvia (Sitagliptin), Galvus (Vildagliptin), Onglyza (Saxagliptin), Tradjenta (Linagliptin) are the major DPP-4 drugs in the market.
The global Dipeptide Peptidase 4 (DPP-4) Inhibitors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Dipeptide Peptidase 4 (DPP-4) Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dipeptide Peptidase 4 (DPP-4) Inhibitors market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Dipeptide Peptidase 4 (DPP-4) Inhibitors in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Dipeptide Peptidase 4 (DPP-4) Inhibitors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Merck
Eli Lilly
AstraZenica
Boehringer Ingelheim
Takeda Pharmaceutical Company
BMS
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Sitagliptin
Saxagliptin
Linagliptin
Alogliptin
Vildagliptin
Segment by Application
Hospitals
Clinics
Table of Contents
Executive Summary
1 Industry Overview of Dipeptide Peptidase 4 (DPP-4) Inhibitors
- 1.1 Definition of Dipeptide Peptidase 4 (DPP-4) Inhibitors
- 1.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Type
- 1.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Sitagliptin
- 1.2.3 Saxagliptin
- 1.2.4 Linagliptin
- 1.2.5 Alogliptin
- 1.2.6 Vildagliptin
- 1.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Applications
- 1.3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Overall Market
- 1.4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2014-2025)
- 1.4.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production (2014-2025)
- 1.4.3 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Status and Prospect (2014-2025)
- 1.4.4 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Status and Prospect (2014-2025)
- 1.4.5 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Status and Prospect (2014-2025)
- 1.4.6 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Status and Prospect (2014-2025)
- 1.4.8 India Dipeptide Peptidase 4 (DPP-4) Inhibitors Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors
- 2.3 Manufacturing Process Analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors
- 2.4 Industry Chain Structure of Dipeptide Peptidase 4 (DPP-4) Inhibitors
3 Development and Manufacturing Plants Analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Dipeptide Peptidase 4 (DPP-4) Inhibitors
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Production and Capacity Analysis
- 4.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Analysis
- 4.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Price Analysis
- 4.4 Market Concentration Degree
5 Dipeptide Peptidase 4 (DPP-4) Inhibitors Regional Market Analysis
- 5.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Production by Regions
- 5.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production by Regions
- 5.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Regions
- 5.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption by Regions
- 5.3 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Analysis
- 5.3.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Production
- 5.3.2 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Import and Export
- 5.4 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Analysis
- 5.4.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Production
- 5.4.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Import and Export
- 5.5 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Analysis
- 5.5.1 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Production
- 5.5.2 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Import and Export
- 5.6 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Analysis
- 5.6.1 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Production
- 5.6.2 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Import and Export
- 5.7 Southeast Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Analysis
- 5.7.1 Southeast Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Production
- 5.7.2 Southeast Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Import and Export
- 5.8 India Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Analysis
- 5.8.1 India Dipeptide Peptidase 4 (DPP-4) Inhibitors Production
- 5.8.2 India Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Dipeptide Peptidase 4 (DPP-4) Inhibitors Import and Export
6 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment Market Analysis (by Type)
- 6.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Production by Type
- 6.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type
- 6.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type
7 Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment Market Analysis (by Application)
- 7.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption by Application
- 7.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Market Share by Application (2014-2019)
8 Dipeptide Peptidase 4 (DPP-4) Inhibitors Major Manufacturers Analysis
- 8.1 Merck
- 8.1.1 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Sites and Area Served
- 8.1.2 Merck Product Introduction, Application and Specification
- 8.1.3 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Eli Lilly
- 8.2.1 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Sites and Area Served
- 8.2.2 Eli Lilly Product Introduction, Application and Specification
- 8.2.3 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 AstraZenica
- 8.3.1 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Sites and Area Served
- 8.3.2 AstraZenica Product Introduction, Application and Specification
- 8.3.3 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Boehringer Ingelheim
- 8.4.1 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Sites and Area Served
- 8.4.2 Boehringer Ingelheim Product Introduction, Application and Specification
- 8.4.3 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Takeda Pharmaceutical Company
- 8.5.1 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Sites and Area Served
- 8.5.2 Takeda Pharmaceutical Company Product Introduction, Application and Specification
- 8.5.3 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 BMS
- 8.6.1 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Sites and Area Served
- 8.6.2 BMS Product Introduction, Application and Specification
- 8.6.3 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
9 Development Trend of Analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- 9.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Trend Analysis
- 9.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Regional Market Trend
- 9.2.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Forecast 2019-2025
- 9.2.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Forecast 2019-2025
- 9.2.3 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Forecast 2019-2025
- 9.2.4 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Forecast 2019-2025
- 9.2.5 Southeast Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Forecast 2019-2025
- 9.2.6 India Dipeptide Peptidase 4 (DPP-4) Inhibitors Forecast 2019-2025
- 9.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Trend (Product Type)
- 9.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Dipeptide Peptidase 4 (DPP-4) Inhibitors. Industry analysis & Market Report on Dipeptide Peptidase 4 (DPP-4) Inhibitors is a syndicated market report, published as Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
